Luca Guardabassi

Title: Innovations by Luca Guardabassi in MRSA Detection

Introduction

Luca Guardabassi is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of microbiology, particularly in the detection of antibiotic-resistant bacteria. His work focuses on the development of diagnostic tests that can identify specific strains of Methicillin-resistant Staphylococcus aureus (MRSA), which pose a serious threat to human health.

Latest Patents

Luca Guardabassi holds 1 patent related to MRSA CC398. This patent describes a new diagnostic test for the identification of MRSA CC398, a clone that has emerged in pigs and other domestic animals worldwide. The test utilizes a single one-step PCR method that can be performed easily within a few hours. It targets a specific gene (sau1hsdS1) located on the chromosome of the bacterial species, allowing for rapid identification of the MRSA clone. The test also detects the gene conferring methicillin resistance (mecA), enabling quick differentiation between methicillin-susceptible and methicillin-resistant variants. Preliminary validation of the test showed 100% sensitivity and specificity, making it a valuable tool for surveillance and control of MRSA CC398 in humans, animals, and food products.

Career Highlights

Luca has worked at prestigious institutions such as Statens Serum Institut and the University of Copenhagen. His experience in these organizations has contributed to his expertise in microbiology and diagnostics.

Collaborations

Luca has collaborated with notable coworkers, including Marc Stegger and Jodi Lindsay, who have contributed to his research and development efforts.

Conclusion

Luca Guardabassi's innovative work in the field of MRSA detection highlights the importance of rapid diagnostic tests in combating antibiotic resistance. His contributions are crucial for public health and safety.